Consensus Pfizer, Inc.

Equities

PFE

US7170811035

Market Closed - Nyse 04:00:23 2024-03-18 pm EDT 5-day change 1st Jan Change
27.72 USD -0.79% Intraday chart for Pfizer, Inc. -2.29% -3.72%

Evolution of the average Target Price on Pfizer, Inc.

Price target over the last 5 years

History of analyst recommendation changes

00b7aa260.aDzVUaPuyHrW5SRbti7Ya4t6eYDE6deqovVy20vcQZ4.XHfsBtmarCjv1Bws2nqzAbpJFdezg4jYx6QVqAGfLOggCuUplIz8LO6tVw~e40a430f02eadfedbd92552e67ebb4fa
PFIZER INC : JP Morgan sticks Neutral ZD
PFIZER INC : JP Morgan sticks Neutral ZD
Guggenheim Initiates Pfizer With Buy Rating, Price Target is $36 MT
China move leaves markets unfazed Our Logo
Indian shares set to open higher ahead of national budget RE
UBS Trims Pfizer Price Target to $28 From $29, Maintains Neutral Rating MT
PFIZER INC : UBS gives a Neutral rating ZD
PFIZER INC : Buy rating from Jefferies ZD
PFIZER INC : DZ Bank maintains a Buy rating ZD
PFIZER INC : JP Morgan gives a Neutral rating ZD
PFIZER INC : UBS reaffirms its Neutral rating ZD
PFIZER INC : JP Morgan remains Neutral ZD
PFIZER INC : Berenberg gives a Neutral rating ZD
PFIZER INC : Gets a Neutral rating from JP Morgan ZD
UBS Adjusts Pfizer Price Target to $29 From $27, Maintains Neutral Rating MT
WHO sees 'incredibly low' COVID, flu vaccination rates as cases surge RE
Nvidia comes to Wall Street's rescue Our Logo
Berenberg: M&A Dealmaking in Pharmaceutical Sector to Further Accelerate in 2024 MT
TD Cowen Downgrades Pfizer to Market Perform From Outperform, Price Target is $32 MT
Weight-loss drugs: Who, and what, are they good for? RE
PFIZER INC : DZ Bank maintains a Buy rating ZD
Morgan Stanley Trims Price Target on Pfizer to $28 From $31, Keeps Equalweight Rating MT
UBS Cuts Pfizer's Price Target to $27 From $34, Neutral Rating Kept MT
PFIZER INC : UBS reaffirms its Neutral rating ZD
Cantor Fitzgerald Cuts Price Target on Pfizer to $45 From $75, Keeps Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
27.72 USD
Average target price
32.71 USD
Spread / Average Target
+18.02%
High Price Target
50 USD
Spread / Highest target
+80.38%
Low Price Target
26 USD
Spread / Lowest Target
-6.20%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Pfizer, Inc.

JPMORGAN Chris Schott
Guggenheim
UBS
DZ BANK Elmar Kraus
JEFFERIES Akash Tewari
BERENBERG Kerry Holford
TD Cowen
Morgan Stanley
Cantor Fitzgerald
Truist Securities
Daiwa Securities
Wells Fargo Securities
Redburn
JPMorgan Chase
Barclays
Jefferies & Co.
Goldman Sachs
Credit Suisse
SVB Securities LLC
BMO Capital
HSBC
Berenberg Bank
BofA Securities
Atlantic Equities
Citigroup
Mizuho Securities
Atlantic Securities
SVB Leerink
Independent Research
RBC
RBC Capital Markets
J.P. Morgan Chase
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings